Williams Jones Wealth Management’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-67,511
Closed -$1.65M 513
2024
Q3
$1.65M Sell
67,511
-16,014
-19% -$428K 0.02% 213
2024
Q2
$2.1M Sell
83,525
-5,910
-7% -$168K 0.03% 186
2024
Q1
$2.68M Sell
89,435
-60,702
-40% -$1.78M 0.03% 169
2023
Q4
$4.78M Sell
150,137
-7,406
-5% -$233K 0.07% 129
2023
Q3
$5.56M Sell
157,543
-2,100
-1% -$80K 0.09% 125
2023
Q2
$6.07M Sell
159,643
-2,458
-2% -$98K 0.09% 125
2023
Q1
$6.12M Sell
162,101
-10,822
-6% -$416K 0.1% 129
2022
Q4
$7.33M Buy
172,923
+1,248
+0.7% +$51.4K 0.12% 120
2022
Q3
$5.52M Sell
171,675
-11,748
-6% -$413K 0.1% 132
2022
Q2
$5.96M Sell
183,423
-72,034
-28% -$2.33M 0.1% 134
2022
Q1
$9.24M Sell
255,457
-14,677
-5% -$504K 0.13% 103
2021
Q4
$10.7M Buy
270,134
+54,847
+25% +$2.29M 0.13% 99
2021
Q3
$9.41M Sell
215,287
-1,150
-0.5% -$51.6K 0.13% 102
2021
Q2
$8.84M Buy
216,437
+9,985
+5% +$385K 0.12% 107
2021
Q1
$6.78M Buy
206,452
+20,872
+11% +$785K 0.11% 121
2020
Q4
$7.55M Buy
185,580
+20,130
+12% +$753K 0.12% 100
2020
Q3
$6.06M Buy
165,450
+28,625
+21% +$1.03M 0.11% 103
2020
Q2
$4.64M Buy
136,825
+15,150
+12% +$413K 0.1% 112
2020
Q1
$2.58M Sell
121,675
-44,900
-27% -$1M 0.07% 127
2019
Q4
$3.72M Sell
166,575
-1,100
-0.7% -$24K 0.07% 136
2019
Q3
$3.4M Buy
+167,675
New +$3.3M 0.07% 140

Other funds holding GMAB

Williams Jones Wealth Management's GMAB Position: Q4 2024 in Review

Williams Jones Wealth Management sold out of Genmab (GMAB) in Q4 2024, closing a stake of 67,511 shares — an estimated $1.65M sold.

Williams Jones Wealth Management first reported a position in GMAB in Q3 2019 and held it in 21 quarters. The position peaked at $10.7M in Q4 2021. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

  • Williams Jones Wealth Management reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
  • Williams Jones Wealth Management sold 67,511 Genmab shares in Q4 2024, an estimated $1.65M.
  • Williams Jones Wealth Management first reported a position in Genmab in Q3 2019 and held it in 21 quarters.
  • Williams Jones Wealth Management's Genmab position peaked at $10.7M in Q4 2021.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Williams Jones Wealth Management's 13F filing for Q4 2024, filed 14 Feb 2025.